Results 21 to 30 of about 199,597 (317)
AbstractThe clinical phenotype of somatic mutations in endometriosis is unknown. The objective was to determine whether somatic KRAS mutations were associated with greater disease burden in endometriosis (i.e. more severe subtypes and higher stage). This prospective longitudinal cohort study included 122 subjects undergoing endometriosis surgery at a ...
Natasha L Orr +15 more
openaire +3 more sources
Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer
Increasing evidence indicates that the abnormal expression of N6-methyladenosine (m6A) modification is closely related to the epigenetic regulation of immune response in breast cancer (BC).
Menglu Dong +4 more
doaj +1 more source
The Clinical Implications of Tumor Mutational Burden in Osteosarcoma [PDF]
BackgroundOsteosarcoma (OTS) is aggressive bone malignancy without well-recognized prognosis biomarker. Tumor mutational burden (TMB) has been proved as effective biomarker in predicting clinical outcomes in several cancer types. However, its prognostic value in OTS remains unknown.
Lu Xie +11 more
openaire +3 more sources
Recent studies have shown that RNA N6-methyladenosine (m6A) modification plays an important part in tumorigenesis and immune-related biological processes.
Mengyu Sun +11 more
doaj +1 more source
Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer [PDF]
Background. It has been shown that low-density lipoprotein receptor-related protein 1B (LRP1B) mutations correlate with tumor mutation burden (TMB) and prognosis in patients with melanoma and non-small-cell lung cancer, while the relationship between LRP1B mutations and TMB in gastric cancer needs further study.
Sizhe Hu +4 more
openaire +2 more sources
Cancer immunotherapy: broadening the scope of targetable tumours [PDF]
Cancer immunotherapy has experienced remarkable advances in recent years. Striking clinical responses have been achieved for several types of solid cancers (e.g.
Jitske van den Bulk +2 more
doaj +1 more source
Prognostic Value and Therapeutic Perspectives of CXCR Members in the Glioma Microenvironment
Background: CXCR (CXC Chemokine Receptor) is a complex of the immune-associated protein involved in tumor activation, invasion, migration, and angiogenesis through various chemical signals in the tumor microenvironment (TME).
Jiarong He +6 more
doaj +1 more source
BackgroundEpigenetic changes of lung adenocarcinoma (LUAD) have been reported to be a relevant factor in tumorigenesis and cancer progression. However, the molecular mechanisms responsible for DNA methylation patterns in the tumor immune-infiltrating ...
Didi Yuan +8 more
doaj +1 more source
Background: The non-negligible role of epigenetic modifications in cancer development and tumor microenvironment (TME) has been demonstrated in recent studies. Nonetheless, the potential regulatory role of N7-methylguanosine (m7G) modification in shaping
Shouzheng Ma +9 more
doaj +1 more source
A polygenic burden of rare disruptive mutations in schizophrenia [PDF]
By analyzing the exome sequences of 2,536 schizophrenia cases and 2,543 controls, we have demonstrated a polygenic burden primarily arising from rare (
Purcell, S.M. +31 more
openaire +6 more sources

